New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 6, 2012
07:18 EDTCRISCuris announces U.S. patent issuance covering HSP90 inhibitor Debio 0932
Curis announced that the U.S. Patent and Trademark Office has issued a patent covering a genus of compounds that includes Debio 0932, an orally-administered Heat Shock Protein 90, or HSP90, inhibitor, which is being developed by Curis' licensee Debiopharm. The newly issued patent, U.S. Patent Number 8,324,240, is entitled "Fused Amino Pyridine as HSP90 Inhibitors."
News For CRIS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 19, 2015
15:37 EDTCRISCuris, Aurigene to present data on IRAK-4 inhibitor program
Subscribe for More Information
April 17, 2015
16:04 EDTCRISCuris files to sell 17.12M shares of common stock for holders
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use